Skip to content

NBP

NovaBridge Biosciences

NASDAQ · Healthcare · Biotechnology · US

$1.62
−0.61%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue4.5M(10.7M)
Cost of Revenue
Gross Profit4.5M(10.7M)
Operating Expenses
R&D Expense25.4M9.0M158.9M114.4M155.5M
SG&A Expense34.6M4.5M216.5M63.9M199.9M
General & Admin Expense34.6M4.5M216.5M63.9M199.9M
Selling & Marketing Expense
Other Expenses(118.64)337.4M(247.00)
Total Operating Expenses60.1M13.5M375.4M515.6M355.4M
Cost and Expenses60.1M13.5M375.4M515.6M355.4M
Operating Income (EBIT)(60.1M)(13.5M)(375.4M)(511.2M)(366.1M)
Non-Operating
Interest Income2.4M1.1M54.6M7.3M5.0M
Interest Expense101.9K
Net Interest Income4.7M1.1M54.6M7.2M5.0M
Other Non-Op Income/Expense5.0M847.6K12.6M(954.5M)(607.1M)
Non-Operating Income (excl Interest)(163.5M)
EBT (Pre-Tax Income)(55.0M)(12.6M)(362.7M)(1.5B)(973.2M)
Income Tax Expense(1.3B)(5.6M)
Bottom Line
Net Income(49.0M)(6.6M)(162.3M)(1.5B)(967.5M)
Earnings from Cont. Ops(55.0M)(12.6M)(362.7M)(206.8M)(967.5M)
Earnings from Discont. Ops200.5M
Bottom Line Net Income(49.0M)(6.6M)(362.7M)(1.5B)(967.5M)
Per Share
Basic EPS($0.57)($0.16)($4.46)($17.62)($30.38)
Diluted EPS($0.57)($0.16)($4.46)($17.62)($30.38)
Revenue Per Share$0.00$0.00$0.00$0.05($0.13)
Shares
Basic Shares Outstanding115.7M41.6M81.2M83.2M82.5M
Diluted Shares Outstanding115.7M41.6M81.2M83.2M82.5M
Profitability Metrics
EBITDA(59.7M)(13.4M)(373.5M)(344.3M)(356.4M)
D&A321.8K122.4K1.9M3.4M9.7M
EBIT(60.1M)(13.5M)(375.4M)(347.6M)(366.1M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026